Scribe Therapeutics Inc <SCTX.O>: Leerink Partners initiates coverage with outperform rating; price target $37
SCTX•Related News
Legacy Housing names co-founder Kenneth Shipley chairman, CEO
LEGH•
Vision Marine unit Nautical Ventures adds Tahoe Pontoons dealership on Florida Gulf Coast
VMAR•
Oil market starts pricing in a prolonged Hormuz crisis: Bousso
XLE•
IHG signs first Hotel Indigo branded residences project at Mountain View Ras El Hekma in Egypt
IHG•
Home Depot tops second-quarter estimates on steady repair demand
HD•